CSIMarket Company Name, Ticker, Competitors, else..
 
Dentsply Sirona Inc   (XRAY)
Other Ticker:  
 
 
Price: $32.6800 $0.13 0.399%
Day's High: $32.7 Week Perf: 3.81 %
Day's Low: $ 32.24 30 Day Perf: 14.51 %
Volume (M): 72 52 Wk High: $ 43.24
Volume (M$): $ 2,359 52 Wk Avg: $36.32
Open: $31.70 52 Wk Low: $26.27



 Market Capitalization (Millions $) 6,922
 Shares Outstanding (Millions) 212
 Employees 15,000
 Revenues (TTM) (Millions $) 3,936
 Net Income (TTM) (Millions $) -219
 Cash Flow (TTM) (Millions $) -109
 Capital Exp. (TTM) (Millions $) 141

Dentsply Sirona Inc
DENTSPLY believes it is the worlds largest designer, developer, manufacturer and marketer of a broad range of products for the dental market. The Companys worldwide headquarters and executive offices are located in York, Pennsylvania. In addition to the United States ('U.S.'), the Company conducts its business in over 120 foreign countries, principally through its foreign subsidiaries. DENTSPLY has a long-established presence in Canada and in the European market, particularly in Germany, Switzerland, France, Italy and the United Kingdom. The Company also has a significant market presence in Central and South America including Brazil, Mexico, Argentina, Colombia and Chile; in South Africa; and in the Pacific Rim including Japan, Australia, New Zealand, China (including Hong Kong), Thailand, India, Philippines, Taiwan, South Korea, Vietnam and Indonesia. DENTSPLY has also established marketing activities in Moscow, Russia to serve the countries of the former Soviet Union.


   Company Address: 13320 Ballantyne Corporate Place Charlotte 28277 NC
   Company Phone Number: 848-0137   Stock Exchange / Ticker: NASDAQ XRAY
   XRAY is expected to report next financial results on February 29, 2024. Next quarterly dividend pay out on January 08, 2024.


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
PDCO   -17.59%    
DHR        1.59% 
• View Complete Report
   



Aurora Technology Acquisition Corp

Aurora Technology Acquisition Corp Faces Declining Operating Behavior, Raising Concerns in Q3 2023

An Overview of Aurora Technology Acquisition Corp's Third Quarter Earnings
As the July to September 30, 2023 earnings season progresses, various companies across different industries are reporting their financial results. One such industry is the Medical Equipment and Supplies sector, which has seen many corporations release their earnings reports. Among them is Aurora Technology Acquisition Corp (ATAK), which recently announced an operating deficit of -$0.4793 million for the third quarter of 2023.
Comparing this figure to the same period in 2022, we can observe a deteriorating operating deficit. In the third quarter of 2022, ATAK reported an operating deficit of -$0.21933 million. This decline raises questions among market participants about the company's ability to generate revenue.
Vivos Therapeutics Inc

Vivos Therapeutics Inc. Defies Financial Odds in the Demanding Times of September 2023

For the fiscal time-frame closing September 30 2023 Vivos Therapeutics Inc decreased a loss per share of $-1.75 per share compare to $-6.50 a year before and Income per Share improved from $-4.50 per share from the preceding reporting season. The revenue crumbled by -31.748 % to $2.90 million from $4.25 million in the corresponding reporting season a year before and sequentially Revenue decreased by -6.456 % from $3.10 million.

Vystar Corporation

Devastating Blow: Medical Equipment and Supplies Company Suffers Major Setback in Q3 2023 Financial Report



Over the past five days, Vystar Corporation has experienced a significant drop in its stock price, declining by -37.78%. Furthermore, the stock is currently trading -20.9% below its 52-week average. In order to better understand the reasons behind this decline, it is essential to examine Vystar Corporation's financial performance for the recent reporting season, which ended on September 30, 2023.
Earnings Per Share and Revenue:
Vystar Corporation reported a considerable improvement in its financial health compared to the previous year. The loss per share decreased from $-0.23 to $-0.03, while the income per share improved from $-0.04. In terms of revenue, there was a significant decline of -98.311% from $3.57 million to $0.06 million compared to the same reporting season a year prior. However, sequentially, the revenue saw an increase of 67.054% from $0.04 million.
Petvivo Holdings Inc

Petvivo Holdings Inc Experiences Widening Losses in Q2 2024 Amid Decrease in Orders


As an investor closely following Petvivo Holdings Inc, the recent financial results have presented a mixed bag of challenges and opportunities. In the second quarter of 2024, the company experienced lower turnover, resulting in a significant revenue decrease and a larger shortfall per share compared to the previous year. However, there were notable signs of potential growth and increasing demand within the Medical Equipment and Supplies industry.
One of the key financial indicators is the revenue, which decreased by -7.127% to $0.21 million year on year. This decline is concerning for Petvivo Holdings Inc, as it points to potential shortcomings in the company's ability to generate sales. Comparatively, the Medical Equipment and Supplies industry as a whole recorded a top-line rise in the same period, suggesting that Petvivo may be facing certain internal challenges.
Ir Med Inc

Ir Med Inc announced operating profit of $1.197 million, in the third quarter of 2023 financial report


As an observer of the Medical Equipment and Supplies sector, I have thoroughly analyzed the third quarter financial results of Ir Med Inc. The company's performance took center stage in this report, overshadowing the same period in the previous year. Despite operating predominantly in the development phase, Ir Med Inc showcased a bullish quarter, signaling potential growth prospects.
Notably, Ir Med Inc reported an operating profit of $1.197 million for the July to September 30, 2023 quarter, without any reported revenue. This indicates that the company is focusing on developing its services rather than generating immediate revenue. Such a strategic course of action is crucial for a business aiming to establish a strong foundation before entering the market.





 

Dentsply Sirona Inc's Segments
 
Consumable Businesses
 Segment     of total Revenue
Select Distribution Businesses
 Segment     of total Revenue
Healthcare Emerging Markets Businesses
 Segment     of total Revenue
Precious metal content
 Segment     of total Revenue
 
• View Complete Report
  Company Estimates  
  • Revenue Outlook
Dentsply Sirona Inc does not provide revenue guidance.

• Earnings Outlook
Dentsply Sirona Inc does not provide earnings estimates.

 
Geographic Revenue Dispersion
United States
Germany
Sweden
Other International




Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com